Rigel Pharmaceuticals

Home » Rigel Pharmaceuticals

Secondary

Rigel Pharmaceuticals

We are a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematological disorders, cancer and rare diseases.

Symbol

RIGL

Final Price
$3.88

Shares
16,000,000

Anticipated Date
TBD

Underwriters
Jefferies, Piper Jaffray, BMO Capital Markets, H.C. Wainwright & Co.

To view the prospectus for Rigel Pharmaceuticals, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253